Bill > H1240

This bill addresses insulin access and affordability by implementing several key provisions across different healthcare and insurance contexts. The bill establishes a $100 cap for a 30-day insulin supply for individuals across various insurance types, including state employee health plans, Medicaid, private insurers, health maintenance organizations (HMOs), and preferred provider organizations (PPOs). Additionally, the bill requires pharmaceutical manufacturers to establish an insulin patient assistance program for individuals who urgently need insulin and meet specific eligibility criteria, including being a U.S. citizen or legal resident with a household income at or below 400% of the federal poverty guidelines and lacking private prescription drug coverage. The program must provide a one-time, 30-day free insulin supply annually, with manufacturers required to make application forms available online, respond to applications within 14 days, and enroll eligible applicants for one year. Pharmaceutical companies that fail to comply with these requirements can be fined $100,000 per month of non-compliance. The bill also allows manufacturers to create single-use vouchers redeemable at pharmacies for individuals with urgent insulin needs, providing a flexible mechanism to help patients access necessary medication.

Business and Industry

https://malegislature.gov/Bills/194/H1240